An Observational Study of MabThera/Rituxan (Rituximab) Plus Chemotherapy As First-Line Treatment in Patients With Diffuse Large B-Cell Lymphoma or Follicular Lymphoma
Clinical trial NCT01340443 · COMPLETED
Trial details
- NCT number
- NCT01340443
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2011-01-19
- Primary completion
- 2016-07-15
- Enrollment
- 314
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.